Artículos por temáticas

Comparative assessment of organic and inorganic tea leaf extract feeding on anxiety behaviour status of colchicine-induced rat model of Alzheimer's disease

Bagchi A, Swain DK, Mitra A.

Inflammopharmacology. 2022 Apr;30(2):609-620. doi: 10.1007/s10787-022-00943-x. Epub 2022 Mar 9.

Safety, Tolerability and Pharmacokinetics of Icapamespib, a Selective Epichaperome Inhibitor, in Healthy Adults

Silverman MH, Duggan S, Bardelli G, Sadler B, Key C, Medlock M, Reynolds L, Wallner B.

J Prev Alzheimers Dis. 2022;9(4):635-645. doi: 10.14283/jpad.2022.71.

Cost-Effectiveness of the Comprehensive Interdisciplinary Program-Care in Informal Caregivers of People with Alzheimer's Disease

Muñoz-Bermejo L, González-Becerra MJ, Barrios-Fernández S, Postigo-Mota S, Jerez-Barroso MDR, Martínez JAF, Suárez-Lantarón B, Marín DM, Martín-Bermúdez N, Ortés-Gómez R, Gómez-Ullate-García de León M

Int J Environ Res Public Health. 2022 Nov 18;19(22):15243. doi: 10.3390/ijerph192215243.

Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis

Browning JA, Tsang CCS, Dong X, Wan JY, Chisholm-Burns MA, Finch CK, Tsao JW, Liu C, Wang J.

BMC Health Serv Res. 2022 Feb 7;22(1):159. doi: 10.1186/s12913-022-07483-8.

The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflow

Lorenzini L, Ingala S, Wink AM, Kuijer JPA, Wottschel V, Dijsselhof M, Sudre CH, Haller S, Molinuevo JL, Gispert JD, Cash DM, Thomas DL, Vos SB, Prados F, Petr J, Wolz R, Palombit A, Schwarz AJ, Chéte

Neuroimage Clin. 2022;35:103106. doi: 10.1016/j.nicl.2022.103106. Epub 2022 Jul 7.

Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid

Yaari R, Holdridge KC, Choi J, Donohue MC, Kantarci K, Jack CR Jr, Zuk SM, Sims JR, Johnson KA, Aisen PS, Sperling RA.

J Prev Alzheimers Dis. 2022;9(4):617-624. doi: 10.14283/jpad.2022.56.

A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease Pathogenesis

Shukla M, Wongchitrat P, Govitrapong P.

Neurochem Res. 2022 May;47(5):1166-1182. doi: 10.1007/s11064-022-03530-2. Epub 2022 Feb 5.

The Impact of Physical Exercise on the Hippocampus in Physiological Condition and Ageing-Related Decline: Current Evidence from Animal and Human Studies

Lauretta G, Ravalli S, Maugeri G, D'Agata V, Rosa MD, Musumeci G.

Curr Pharm Biotechnol. 2022;23(2):180-189. doi: 10.2174/1389201022666210405142611.

Sixteen Weeks of Aerobic Exercise does not Alter Resting-state Connectivity of the Precuneus in Patients with Alzheimer's Disease

Musaeus CS, Johansen LB, Hasselbalch S, Beyer N, Høgh P, Siebner HR, Frederiksen KS.

Curr Alzheimer Res. 2022;19(2):171-177. doi: 10.2174/1567205019666220304091241.

A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease

Schneider LS, Laudon M, Nir T, Caceres J, Ianniciello G, Capulli M, Zisapel N.

J Prev Alzheimers Dis. 2022;9(2):247-254. doi: 10.14283/jpad.2021.61.

Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM

Byun J, Lee DY, Jeong CW, Kim Y, Rhee HY, Moon KW, Heo J, Hong Y, Kim WJ, Nam SJ, Choi HS, Park JI, Chun IK, Bak SH, Lee K, Byeon GH, Kim KL, Kim JA, Park YJ, Kim JH, Lee EJ, Lee SA, Kwon SO, Park SW,

Sci Rep. 2022 Mar 15;12(1):4451. doi: 10.1038/s41598-022-08595-1.

Clausena Harmandiana root extract attenuated cognitive impairments via reducing amyloid accumulation and neuroinflammation in Aβ(1-42)-induced rats

Nillert N, Boonyarat C, Welbat JU, Bunreungthong K, Puthongking P, Pannangrong W.

BMC Complement Med Ther. 2022 Apr 19;22(1):108. doi: 10.1186/s12906-022-03591-4.

Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey

DiStefano MJ, Alexander GC, Polsky D, Anderson GF.

J Am Geriatr Soc. 2022 Jun;70(6):1685-1694. doi: 10.1111/jgs.17692. Epub 2022 Feb 7.

Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease

Baakman AC, Gavan C, van Doeselaar L, de Kam M, Broekhuizen K, Bajenaru O, Camps L, Swart EL, Kalisvaart K, Schoonenboom N, Lemstra E, Scheltens P, Cohen A, van Gerven J, Groeneveld GJ.

Br J Clin Pharmacol. 2022 Jun;88(6):2814-2829. doi: 10.1111/bcp.15206. Epub 2022 Jan 26.

Therapeutic Potential of Allicin and Aged Garlic Extract in Alzheimer's Disease

Tedeschi P, Nigro M, Travagli A, Catani M, Cavazzini A, Merighi S, Gessi S.

Int J Mol Sci. 2022 Jun 22;23(13):6950. doi: 10.3390/ijms23136950.